How did VHT's Momentum indicator behave recently?

The Momentum Indicator moved above the 0 level on July 24, 2026. You may want to consider a long position or call options on VHT as a result. In 66 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

What does a 3-day price advance indicate for VHT?

Following a +1.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where VHT advanced for three days, in 258 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

VHT

AS OF

Aug 13 closing price

Price

$316.22

Change

-$0.46 (-0.15%)

Net Assets

20.9B

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

+Compare

VHT

ETF ticker: NYSE ARCA

AS OF

Aug 13 closing price

Price

$316.22

Change

-$0.46 (-0.15%)

Net Assets

20.9B

VHT

ETF ticker: NYSE ARCA

PRICE

CHANGE

NET ASSETS

VHT stock forecast, quote, news & analysis

Q: How does the Aroon Indicator reflect on VHT's trend?

The Aroon Indicator entered an Uptrend today. In 200 of 241 cases where VHT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 83%.

The investment seeks to track the performance of the MSCI U... Show more

Category: #Health

Get AI intraday signals

VHT

Setup

Daily Signal:

Description

Gain/Loss:

A.I.Advisor

published price charts

Intraday

View AI-Driven Trading for VHT

Interact to see
Advertisement

A.I.Advisor

a Summary for VHT with price predictions

Aug 13, 2026

VHT's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for VHT turned positive on August 10, 2026. Looking at past instances where VHT's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 24, 2026. You may want to consider a long position or call options on VHT as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VHT advanced for three days, in of 317 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 241 cases where VHT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for VHT moved out of overbought territory on August 11, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VHT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VHT broke above its upper Bollinger Band on August 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor

published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Abbott Laboratories (NYSE:ABT), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Intuitive Surgical (NASDAQ:ISRG).

Industry description

The investment seeks to track the performance of the MSCI U.S. Investable Market Index (IMI)/Health Care 25/50. The fund employs an indexing investment approach designed to track the performance of the index, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the GICS. The Advisor attempts to replicate the target index by seeking to invest all, or substantially all, of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.

Market Cap

The average market capitalization across the Vanguard Health Care ETF ETF is 30.48B. The market cap for tickers in the group ranges from 6.2M to 1.08T. LLY holds the highest valuation in this group at 1.08T. The lowest valued company is MODV at 6.2M.

High and low price notable news

The average weekly price growth across all stocks in the Vanguard Health Care ETF ETF was 2%. For the same ETF, the average monthly price growth was 6%, and the average quarterly price growth was 9%. CTEV experienced the highest price growth at 57%, while HRTX experienced the biggest fall at -33%.

Volume

The average weekly volume growth across all stocks in the Vanguard Health Care ETF ETF was -27%. For the same stocks of the ETF, the average monthly volume growth was -11% and the average quarterly volume growth was -34%